Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 79 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic targetAsim, M.; Massie, C.; Orafidiya, F.; Pértega-Gomes, N.; Warren, A.; Esmaeili, M.; Selth, L.; Zecchini, H.; Luko, K.; Qureshi, A.; Baridi, A.; Menon, S.; Madhu, B.; Escriu, C.; Lyons, S.; Vowler, S.; Zecchini, V.; Shaw, G.; Hessenkemper, W.; Russell, R.; et al.
2016Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignanciesLewinsohn, M.; Brown, A.L.; Weinel, L.M.; Phung, C.; Rafidi, G.; Lee, M.K.; Schreiber, A.W.; Feng, J.; Babic, M.; Chong, C.E.; Lee, Y.; Yong, A.; Suthers, G.K.; Poplawski, N.; Altree, M.; Phillips, K.; Jaensch, L.; Fine, M.; D'Andrea, R.J.; Lewis, I.D.; et al.
2015A multicenter randomized trial of continuous versus intermittent β-lactam infusion in severe sepsisDulhunty, J.; Roberts, J.; Davis, J.; Webb, S.; Bellomo, R.; Gomersall, C.; Shirwadkar, C.; Eastwood, G.; Myburgh, J.; Paterson, D.; Starr, T.; Paul, S.; Lipman, J.; Peck, L.; Young, H.; Boschert, C.; Fletcher, J.; Smith, J.; Nand, K.; Sara, T.; et al.
2015Association of cardiometabolic multimorbidity with mortalityEmerging Risk Factors Collaboration,; Di Angelantonio, E.; Kaptoge, S.; Wormser, D.; Willeit, P.; Butterworth, A.; Bansal, N.; O'Keeffe, L.; Gao, P.; Wood, A.; Burgess, S.; Freitag, D.; Pennells, L.; Peters, S.; Hart, C.; Haheim, L.; Gillum, R.; Nordestgaard, B.; Psaty, B.; Yeap, B.; et al.
2015Parallel gene expression changes in sarcoidosis involving the lacrimal gland, orbital tissue, or bloodRosenbaum, J.; Choi, D.; Wilson, D.; Grossniklaus, H.; Harrington, C.; Sibley, C.; Dailey, R.; Ng, J.; Steele, E.; Czyz, C.; Foster, J.; Tse, D.; Alabiad, C.; Dubovy, S.; Parekh, P.; Harris, G.; Kazim, M.; Patel, P.; White, V.; Dolman, P.; et al.
2021Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesityCao, E.; Watt, M.J.; Nowell, C.J.; Quach, T.; Simpson, J.S.; De Melo Ferreira, V.; Agarwal, S.; Chu, H.; Srivastava, A.; Anderson, D.; Gracia, G.; Lam, A.; Segal, G.; Hong, J.; Hu, L.; Phang, K.L.; Escott, A.B.J.; Windsor, J.A.; Phillips, A.R.J.; Creek, D.J.; et al.
2022Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemiaKimura, S.; Montefiori, L.; Iacobucci, I.; Zhao, Y.; Gao, Q.; Paietta, E.M.; Haferlach, C.; Laird, A.D.; Mead, P.E.; Gu, Z.; Stock, W.; Litzow, M.R.; Rowe, J.M.; Luger, S.M.; Hunger, S.P.; Ryland, G.; Schmidt, B.M.; Ekert, P.G.; Oshlack, A.; Grimmond, S.; et al.
2013PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancerDay, F.; Jorissen, R.; Lipton, L.; Mouradov, D.; Sakthianandeswaren, A.; Christie, M.; Li, S.; Tsui, C.; Tie, J.; Desai, J.; Xu, Z.; Molloy, P.; Whitehall, V.; Leggett, B.; Jones, I.; McLaughlin, S.; Ward, R.; Hawkins, N.; Ruszkiewicz, A.; Moore, J.; et al.
2022Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical TrialsMcCleary, N.J.; Harmsen, W.S.; Haakenstad, E.; Cleary, J.M.; Meyerhardt, J.A.; Zalcberg, J.; Adams, R.; Grothey, A.; Sobrero, A.F.; Van Cutsem, E.; Goldberg, R.M.; Peeters, M.; Tabernero, J.; Seymour, M.; Saltz, L.B.; Giantonio, B.J.; Arnold, D.; Rothenberg, M.L.; Koopman, M.; Schmoll, H.-J.; et al.
2021The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort studyHodgson, C.L.; Higgins, A.M.; Bailey, M.J.; Mather, A.M.; Beach, L.; Bellomo, R.; Bissett, B.; Boden, I.J.; Bradley, S.; Burrell, A.; Cooper, D.J.; Fulcher, B.J.; Haines, K.J.; Hopkins, J.; Jones, A.Y.M.; Lane, S.; Lawrence, D.; van der Lee, L.; Liacos, J.; Linke, N.J.; et al.